Lifeist Wellness Inc. (TSXV:LFST)
Canada · Delayed Price · Currency is CAD 0.0350
0.00 (0.00%)
At close: Feb 9, 2026
Lifeist Wellness Income Statement
Financials in millions CAD. Fiscal year is December - November.
Millions CAD. Fiscal year is Dec - Nov.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Aug '25 Aug 31, 2025 | Nov '24 Nov 30, 2024 | Nov '23 Nov 30, 2023 | Nov '22 Nov 30, 2022 | Nov '21 Nov 30, 2021 | Nov '20 Nov 30, 2020 |
| 0.27 | 0.59 | 1.36 | 22.07 | 21.15 | 25.1 | |
Revenue Growth (YoY) | - | -56.86% | -93.81% | 4.36% | -15.77% | 53.63% |
Cost of Revenue | 0.25 | 0.38 | 0.6 | 17.11 | 21.03 | 23.65 |
Gross Profit | 0.02 | 0.2 | 0.76 | 4.96 | 0.12 | 1.46 |
Selling, General & Admin | 2.85 | 4.19 | 6.01 | 18.79 | 20.27 | 23.01 |
Research & Development | - | - | - | 0.13 | 0.63 | 1.69 |
Operating Expenses | 2.52 | 4.64 | 6.95 | 20.08 | 23.88 | 27.66 |
Operating Income | -2.5 | -4.43 | -6.19 | -15.12 | -23.76 | -26.2 |
Interest Expense | -0 | -0.03 | -0.02 | -0 | -0.1 | - |
Interest & Investment Income | 0.05 | 0.04 | - | - | - | 0.25 |
Earnings From Equity Investments | - | - | - | - | - | -0.33 |
Currency Exchange Gain (Loss) | 0 | -0.03 | -0.01 | 0.01 | -0.13 | -1.14 |
Other Non Operating Income (Expenses) | -0.05 | 0.08 | 0.07 | -1.16 | 2.4 | 0.68 |
EBT Excluding Unusual Items | -2.5 | -4.38 | -6.15 | -16.27 | -21.59 | -26.74 |
Merger & Restructuring Charges | - | - | -0.01 | -0.08 | 0.11 | 0.11 |
Gain (Loss) on Sale of Investments | -0.54 | 0.32 | 0.12 | -0.07 | -0.59 | -0.44 |
Asset Writedown | - | - | - | -2.5 | - | - |
Other Unusual Items | - | - | - | - | - | 0.89 |
Pretax Income | -3.04 | -4.05 | -6.04 | -18.92 | -22.07 | -26.18 |
Income Tax Expense | - | - | -0.03 | -0.22 | 0.16 | 0.25 |
Earnings From Continuing Operations | -3.04 | -4.05 | -6.02 | -18.7 | -22.23 | -26.43 |
Earnings From Discontinued Operations | 0.18 | 2.61 | -8.11 | 3.26 | -1.57 | - |
Net Income to Company | -2.87 | -1.45 | -14.13 | -15.44 | -23.8 | -26.43 |
Minority Interest in Earnings | - | - | - | - | - | 0.18 |
Net Income | -2.87 | -1.45 | -14.13 | -15.44 | -23.8 | -26.25 |
Net Income to Common | -2.87 | -1.45 | -14.13 | -15.44 | -23.8 | -26.25 |
Shares Outstanding (Basic) | 38 | 32 | 24 | 21 | 20 | 16 |
Shares Outstanding (Diluted) | 38 | 32 | 24 | 21 | 20 | 16 |
Shares Change (YoY) | 34.42% | 30.30% | 17.17% | 6.74% | 20.41% | 1.20% |
EPS (Basic) | -0.07 | -0.05 | -0.58 | -0.74 | -1.22 | -1.62 |
EPS (Diluted) | -0.07 | -0.05 | -0.58 | -0.74 | -1.22 | -1.62 |
Free Cash Flow | -3.05 | -0.88 | -2.45 | -16.04 | -18.64 | -27.98 |
Free Cash Flow Per Share | -0.08 | -0.03 | -0.10 | -0.77 | -0.96 | -1.73 |
Gross Margin | 6.01% | 34.77% | 55.93% | 22.47% | 0.57% | 5.81% |
Operating Margin | -933.58% | -753.04% | -453.30% | -68.52% | -112.38% | -104.36% |
Profit Margin | -1069.88% | -245.51% | -1034.86% | -69.94% | -112.56% | -104.56% |
Free Cash Flow Margin | -1138.72% | -148.98% | -179.73% | -72.68% | -88.17% | -111.44% |
EBITDA | -2.49 | -4.41 | -6.13 | -13.93 | -22.73 | -24.99 |
EBITDA Margin | - | - | - | -63.13% | -107.48% | -99.54% |
D&A For EBITDA | 0.01 | 0.03 | 0.06 | 1.19 | 1.03 | 1.21 |
EBIT | -2.5 | -4.43 | -6.19 | -15.12 | -23.76 | -26.2 |
EBIT Margin | - | - | - | -68.52% | -112.38% | -104.36% |
Revenue as Reported | - | - | - | 22.07 | 21.15 | 25.1 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.